This product is a recombinant human antibody that recognizes FAP. The antibody was purified by affinity chromatography.
Figure 1 Anti-Human FAP Antibody (TAB-024WM) in WB
Western blot analysis of TAB-024WM was performed with FAP Protein, Human, Recombinant (His Tag).
TAB-024WM incubation concentration: 2ng/μL.
The secondary antibody: HRP-Anti-Human IgG (H+L)
Lane 1: Reducing Antigen (0.1μg)
Lane 2: Reducing Antigen (0.3μg)
Lane 3: Reducing Antigen (0.6μg)
Figure 2 Anti-Human FAP Antibody (TAB-024WM) in ELISA
ELISA analysis of TAB-024WM was performed by coating with FAP Protein, Human, Recombinant (His Tag).
The secondary antibody: HRP-Anti-Human IgG (H+L)
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-211 | Anti-Human FAP Recombinant Antibody (Sibrotuzumab) | ELISA, IP, FC, FuncS, Neut, IF, WB | IgG1 - kappa |
To accurately reference this product in your publication, please use the following citation information:
(Creative Biolabs Cat# TAB-024WM, RRID: AB_3111756)
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.